Photo by Public Domain Pictures on Pexels.com

Grim Outlook for EUR-USD Currency Pair

The EUR-USD Have Fallen on Hard Times and Continue to Fall!

(By Glenford S. Robinson)

The Eurozone is not doing as well as one would’ve hoped with annual GDP growth in the Euro zone edging down to 2.1% in the second quarter from first quarter readings of 2.4% and private consumption growth losing steam.

GDP growth is a major macroeconomic measuring tool used to measure the macroeconomic health of an economy. So, it is not hard to see why the Euro zone currency, the EURO is losing ground against currencies with stronger economies, such as the U.S. with is steady dose of interest rate hikes.

Higher interest rates currencies entice bond market investors to invest in countries with the highest interest rates. When interest rates begin to rise, new bonds will pay investors higher interest rates on their loaned investments than older bonds will.

So, bond investors will invest their money in countries with the highest interest rates and withdraw their money from economies with the lowest interest rates. The U.S. is steadily increasing interest rates while the Eurozone interest rate is set at zero.

The U.S. interest rate is currently at 2.25% and is rumored to increase in the near future, while the Eurozone interest rate is parked at zero with no intention of rising. So, the Eurozone currency (EURO) suffers when it goes up against currencies with higher interest rates like the USD.

The EURO has been under constant and continued pressure since the start of the year in February 1st 2018 when the EUR/USD currency pair hit a high of 1.2523. Since then, there has been a vicious downward cycle culminating into other vicious downward cycles with no end in sight.

As recently as August 14, 2018 the currency pair hit a low of 1.1330. Compared to the EUR/USD current price of 1.1335 as of writing October 31, 2018, it is very likely that the currency pair will again test the 1.1330 level.

The moment the EUR/USD pair went below our red zone level of 1.1358, we knew that the pair would continue its downward trajectory. How did we know this? We knew this because we used our Mstardom Finance proprietary trading strategy to deduce the answer.

We are also predicting that unless there is a major positive news catalyst that could initiate a reversal to the upside from the 1.1300 level, the currency will continue to slide down toward our next red zone price level at 1.1212.

There is no solid macroeconomic reason why the price won’t hit our new red zone target of 1.1212. We have looked at a multitude of signals that have confirmed that our prediction has a very high probability of being correct, and we know in trading that probability rules. So, let’s see what happens in the next two days.

By the way, we are not finished yet. Our next red zone prediction target is at the infamous red zone price level of 1.1066. At this level, anything can happen. A reversal could take place or a continuation of the downward trend could occur. We will probably follow this up with another technical analysis article, but until then, we will speak to you all!

Disclosure: I/we/Mstardom Finance does not have a position in EUR/USD.

Disclaimer: ©Mstardom, Inc., Mstardom.com, Mstardom Finance does not provide investment advice.

Check Also

Alert image

Investor Alerts and Bulletins: The Escheatment Process

Keep your contact information updated. Financial institutions must attempt to notify you before escheating your account. Make sure financial institutions at which you have accounts have your accurate contact information (telephone, e-mail and physical address) to help ensure you receive any notices related to your accounts. If your financial institution sends you mail that is returned as undeliverable, or it cannot reach you through your other contact information, your account may be declared abandoned and end up in escheatment.

GDP Growth Slowed

US Economy Starts to Slow Entering 2019, but Headwinds Ease

The Federal Reserve has signaled that it will postpone further interest rate hikes until signs of rising inflation emerge and cease balance sheet normalization activities towards the end of this year. Stock price gains since the announcement of these policy shifts illustrate that if they are executed, business confidence is likely to rise.

Where can I get business financing?

Horizon Technology Finance Provides Investment Portfolio Update Increases Portfolio Size with $24 Million in Loan Originations; Grows Committed Backlog to $47 Million

"During the third quarter, we experienced solid investment activity, increasing the size of our portfolio and expanding our committed backlog for the second consecutive quarter," said Gerald A. Michaud, President of Horizon. "Our success funding seven loans, totaling more than $24 million, and growing our committed backlog to $47 million underscores the strong demand for our venture debt products to growing life science and technology companies. We believe Horizon will continue to benefit from a robust pipeline of investment opportunities and is well positioned to deliver long-term, disciplined portfolio growth, while ensuring credit quality remains strong."

ECB profit increased in 2018

Financial Statements of the ECB for 2018

The ECB’s net profit is distributed to the euro area national central banks (NCBs). The Governing Council decided to make an interim profit distribution, amounting to €1,191 million, to the euro area NCBs on 31 January 2019. At yesterday’s meeting, the Governing Council decided to distribute the remainder of the profit, amounting to €384 million, on 22 February 2019.

Litigation Photo

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Immune Design shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $9.00 price target on the stock and the Company has approximately $100 million in cash and no long-term debt.

Mergers and Acquisitions

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could meaningfully improve vaccine development," said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “This acquisition builds upon Merck’s industry-leading programs that harness the power of the immune system to prevent and treat disease.”

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

%d bloggers like this: